Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea;Korean Source katG, inhA, rpoB Korean Source

Korean Journal of Laboratory Medicine

Volumn 29, Issue 5, 2009, Pages 455-460

  Cho, Eun Hae ^a   Bae, Hye Kyung ^a   Kang, Seong Ki ^a   Lee, Eun Hee ^a  

^a Green Cross Reference Laboratory   (South Korea)

Author keywords

inhA; katG; Mycobacterium tuberculosis; rpoB

Indexed keywords

BACTERIAL PROTEIN; CATALASE; INHA PROTEIN, MYCOBACTERIUM; ISONIAZID; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASE; RIFAMPICIN; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ARTICLE; DNA SEQUENCE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MULTIDRUG RESISTANCE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SOUTH KOREA;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; ISONIAZID; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; REPUBLIC OF KOREA; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 77949332871     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2009.29.5.455     Document Type: Article

References (18)

1. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000;283: 2537-45.
2. Bai GH, Park YK, Choi YW, Bai HJ, Kim HJ, Chang CL, et al. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007;11:571-6.
3. Bartfai Z, Somoskovi A, Kodmon C, Szabo N, Puskas E, Kosztolanyi L, et al. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 2001;39:3736-9.
4. Musser JM, Kapur V, Williams DL, Kreiswirth BN, van Soolingen D, van Embden JD. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 1996;173:196-202.
5. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993;341:647-50.
6. Cooksey RC, Morlock GP, Glickman S, Crawford JT. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 1997;35:1281-3.
7. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the Geno-Type MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007;45:2635-40.
8. Lee H, Cho SN, Bang HE, Lee JH, Bae GH, Kim SJ, et al. Molecular analysis of rifampin-resistant Mycobacterium tuberculosis isolated from Korea by polymerase chain reaction-single strand conformation polymorphism sequence analysis. Int J Tuberc Lung Dis 1998;2:585-9.
9. Park H, Song EJ, Song ES, Lee EY, Kim CM, Jeong SH, et al. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006;44:1619-24.
10. Coll P, Aragón LM, Alcaide F, Espasa M, Garrigó M, González J, et al. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona. Microb Drug Resist 2005;11:107-14.
11. Kim SJ, Bai GH, Hong YP. Drug-resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis 1997;1:302-8.
12. Choi JC, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, et al. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. J Korean Med Sci 2007;22:677-81.
13. Joh JS, Lee CH, Lee JE, Park YK, Bai GH, Kim EC, et al. The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results. J Korean Med Sci 2007;22:26-9.
14. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006;44:2485-91.
15. Kim SY, Park YJ, Song E, Jang H, Kim C, Yoo J, et al. Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2006;54:203-10.
16. Park YK, Shin S, Ryu S, Cho SN, Koh WJ, Kwon OJ, et al. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods 2005;63:165-72.
17. Abe C, Kobayashi I, Mitarai S, Wada M, Kawabe Y, Takashima T, et al. Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan. J Clin Microbiol 2008;46:2263-8.
18. Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994;263:227-30.